Latest Breaking News On - Tashkent pharma park - Page 3 : comparemela.com

Rafarma Pharmaceuticals, Inc. OTC:(RAFA) is pleased to announce its joint venture with the entity known as The Pharmaceutical Industry Development Agency of Uzbekistan which is essentially the Health Department of Uzbekistan. Together the two organizations will produce medicines for use by public health institutions in the Republic of Uzbekistan. This will entail the acquisition of real property (10 hectares in the established Innovative Scientific Production Pharmaceutical Cluster known as “Tashkent Pharma Park”) and construction of a physical plant on the premises. Projected costs are currently at $82,000,000. Both parties will be tasked with developing a timetable for project completion and implementation (projected time table 2021-2025). Rafarma will supply experts in their respective fields, oversee construction, and supply necessary equipment.

Republic of uzbekistanHealth department of uzbekistanRafarma pharmaceuticals incIndustry development agency of uzbekistanIndustry development agencySecurities exchangePharmaceutical industry development agencyHealth departmentLooking statementsSecurities exchange actOther otc rafaPharmaceutical industryTashkent pharma parkOversee constructionகுடியரசு ஆஃப் உஸ்பெகிஸ்தான்ஆரோக்கியம் துறை ஆஃப் உஸ்பெகிஸ்தான்